Search Results

Pages

  • The Lung Unit provides state-of-the-art treatment for all forms and stages of lung cancer and mesothelioma within the framework of a comprehensive clinical research programme.

  • ​Lung cancer includes non-small cell, small cell, mesothelioma, thymoma and neuroendocrine tumours. The Royal Marsden offers a full range of lung cancer treatments and care services.

  • Lung cancer is the second most common cancer in the UK. More men than women develop lung cancer, but the number of women is rising while the number of men is falling.

  • The Lung Unit at The Royal Marsden comprises a team of clinical staff specialising in medicine, radiotherapy and diagnostic imaging.

  • The Royal Marsden is one of a handful of centres in the world that can offer every lung patient a personalised approach to treatment, thanks to our successful research programmes.

  • In this seminar two experts will talk about how we can work towards reducing the burden of lung cancer through research and improved treatment methods. 

  • Clinicians from The Royal Marsden have been in Toronto over the past few days, presenting new research and providing expert comment at this year’s World Conference on Lung Cancer (WCLC). 

  • The fourth Royal Marsden lung cancer symposium will tackle burning issues and key challenges facing clinicians treating patients with lung cancer.

  • This fifth Royal Marsden lung cancer symposium will tackle burning issues and key challenges facing clinicians treating patients with lung cancer.

  • Today sees the UK launch of nivolumab, a new treatment option 'milestone' for lung cancer patients with advanced or metastatic squamous non-small cell lung cancer (NSCLC), which affects a third of all lung cancer patients.

Pages